Alterations of fast axoplasmic transport in experimental methyl n-butyl ketone neuropathy

Brain Res. 1977 Sep 9;133(1):107-18. doi: 10.1016/0006-8993(77)90052-x.

Abstract

Methyl n-butyl ketone (MBK) is known to produce a giant axonal neuropathy in man and experimental animals characterized pathologically by a gradual increase in the number of neurofilaments which become associated with focal areas of axonal swelling and thinning of the myelin sheath. Fast axoplasmic transport was studied in rats exposed to MBK. In 10 severely paralyzed rats exposed to MBK there was a significant impediment of fast axoplasmic transport following dorsal root ganglion injections (x +/- S.D. = 283.2 +/- 20.34 mm/day) compared to normal controls (417.6 +/- 23.78 mm/day). In rats undergoing injections into the ventral horn of the spinal cord there was a gradual impairment of the mean down flow rate for transport of [3H]leucine which correlated with the severity of the MBK induced neuropathy. Quantitative morphological determinations showed that the total number of neurotubules per unit cross-sectional myelin area and the number of neurotubules associated with mitochondria in swollen axons was unchanged from normal. The total number of mitochondria in randomly sampled axons varied significantly from controls but the absolute number of mitochondria associated with neurotubules was unchanged from normal. The results of these studies suggest that the impediment of fast axoplasmic transport may be related to the increased neurofilaments producing focal areas of axonal blockage.

MeSH terms

  • Animals
  • Axonal Transport / drug effects*
  • Axons / drug effects
  • Ganglia, Spinal / drug effects
  • Ketones / toxicity*
  • Methyl n-Butyl Ketone / toxicity*
  • Mitochondria / drug effects
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / physiopathology
  • Rats
  • Sciatic Nerve / drug effects
  • Spinal Cord / drug effects

Substances

  • Ketones
  • Methyl n-Butyl Ketone